晚期非小细胞肺癌个体化治疗周彩存课件.pptVIP

晚期非小细胞肺癌个体化治疗;个体化治疗;影响药物敏感性的因素;Prognostic versus predictive biomarkers: they are not always the same;Factors used to individualized cancer treatment;;First line gefitinib for poor PS patients with EGFR mutations;Efficacy ; DNA修复基因的SNP;;Survival in Doc/Cis treated stage IV NSCLC pts with PS 0 according to ERCC1 C8092A SNP;XRCC1 和XPD SNP与含铂方案疗效之间的关系;分期;Genetic polymorphisms correlate with OS in advanced NSCLC treated with taxol/carbo;;  Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced non-small cell lung cancer patients ;The patients with ER